Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07386418

Study of Lesion-Specific Invasive Haemodynamic Angina Thresholds

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Imperial College London · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

ORBITA-SOLAR is an invasive physiological cardiac catheterisation study that aims to determine whether different coronary stenoses have different angina thresholds. The angina threshold is defined as the amount of coronary flow reduction required to reproduce symptoms. Sixty patients with symptoms of stable angina and 2 coronary artery stenoses amenable to percutaneous coronary intervention (PCI) will be recruited. This study will use intra-coronary balloon inflation during supine exercise on an ergometer to measure the fractional flow reserve (FFR) and non-hyperemic pressure ratio (NHPR) that relates to angina onset, in real time, at the location of each stenosis.

Conditions

Interventions

TypeNameDescription
PROCEDUREPercutaneous coronary intervention (PCI)Clinically indicated PCI for the management of stable angina
DIAGNOSTIC_TESTMeasurement of the angina thresholdFollowing stenting, the order in which to perform the angina threshold assessment at the location of each stent will be randomised. A non-compliant balloon with gradually be inflated over a pressure wire within the deployed stent to re-introduce stenosis. Simultaneously, the participant will exercise on a supine ergometer. At the point when angina is reproduced, the patient will rest and further balloon inflation will stop. Physiological measurements using the pressure wire will be taken with the inflated balloon in situ. This will represent the invasive physiological angina threshold. The balloon will then be deflated and removed. These steps will be repeated at the location of the second stent.

Timeline

Start date
2026-02-10
Primary completion
2028-12-01
Completion
2028-12-01
First posted
2026-02-04
Last updated
2026-02-18

Locations

6 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT07386418. Inclusion in this directory is not an endorsement.